150 related articles for article (PubMed ID: 37337426)
1. Inflammasomes in breast cancer: the ignition spark of progression and resistance?
Elgohary S; El Tayebi HM
Expert Rev Mol Med; 2023 Jun; 25():e22. PubMed ID: 37337426
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients.
Elgohary S; Eissa RA; El Tayebi HM
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762557
[TBL] [Abstract][Full Text] [Related]
3. Targeting inflammasome/IL-1 pathways for cancer immunotherapy.
Guo B; Fu S; Zhang J; Liu B; Li Z
Sci Rep; 2016 Oct; 6():36107. PubMed ID: 27786298
[TBL] [Abstract][Full Text] [Related]
4. Trichothecene mycotoxins activate NLRP3 inflammasome through a P2X7 receptor and Src tyrosine kinase dependent pathway.
Kankkunen P; Välimäki E; Rintahaka J; Palomäki J; Nyman T; Alenius H; Wolff H; Matikainen S
Hum Immunol; 2014 Feb; 75(2):134-40. PubMed ID: 24269698
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.
Ahechu P; Zozaya G; Martí P; Hernández-Lizoáin JL; Baixauli J; Unamuno X; Frühbeck G; Catalán V
Front Immunol; 2018; 9():2918. PubMed ID: 30619282
[TBL] [Abstract][Full Text] [Related]
6. Anti-PD-L1 Antibody Enhances T Cell Immune Responses and Reduces Resistance of Breast Cancer Cells to Radiotherapy.
Guo LM; Ding GF; Xu WC; Ge H; Jiang Y; Lu YF
Oxid Med Cell Longev; 2022; 2022():5938688. PubMed ID: 35295718
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A and inflammasome activation: A link to breast cancer progression?
Fourie C; Shridas P; Davis T; de Villiers WJS; Engelbrecht AM
Cytokine Growth Factor Rev; 2021 Jun; 59():62-70. PubMed ID: 33144050
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the β-cell inflammasome and contribution to stress-induced cellular dysfunction and apoptosis.
Ghiasi SM; Dahllöf MS; Osmai Y; Osmai M; Jakobsen KK; Aivazidis A; Tyrberg B; Perruzza L; Prause MCB; Christensen DP; Fog-Tonnesen M; Lundh M; Grassi F; Chatenoud L; Mandrup-Poulsen T
Mol Cell Endocrinol; 2018 Dec; 478():106-114. PubMed ID: 30121202
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic modulation of inflammasome pathways.
Chauhan D; Vande Walle L; Lamkanfi M
Immunol Rev; 2020 Sep; 297(1):123-138. PubMed ID: 32770571
[TBL] [Abstract][Full Text] [Related]
10. Alarmins, inflammasomes and immunity.
Saïd-Sadier N; Ojcius DM
Biomed J; 2012; 35(6):437-49. PubMed ID: 23442356
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.
Csak T; Ganz M; Pespisa J; Kodys K; Dolganiuc A; Szabo G
Hepatology; 2011 Jul; 54(1):133-44. PubMed ID: 21488066
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis.
Ershaid N; Sharon Y; Doron H; Raz Y; Shani O; Cohen N; Monteran L; Leider-Trejo L; Ben-Shmuel A; Yassin M; Gerlic M; Ben-Baruch A; Pasmanik-Chor M; Apte R; Erez N
Nat Commun; 2019 Sep; 10(1):4375. PubMed ID: 31558756
[TBL] [Abstract][Full Text] [Related]
13. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
[TBL] [Abstract][Full Text] [Related]
15. NLRC4, ASC and Caspase-1 Are Inflammasome Components that Are Mediated by P2Y
Jin H; Kim HJ
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397236
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of Inflammasomes by Pathogens Regulates Inflammation.
Garib FY; Rizopulu AP; Kuchmiy AA; Garib VF
Biochemistry (Mosc); 2016 Nov; 81(11):1326-1339. PubMed ID: 27914458
[TBL] [Abstract][Full Text] [Related]
17. Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival.
Schlotter CM; Tietze L; Vogt U; Heinsen CV; Hahn A
Horm Mol Biol Clin Investig; 2017 Sep; 32(2):. PubMed ID: 28937963
[TBL] [Abstract][Full Text] [Related]
18. Inflammasome, mTORC1 activation, and metabolic derangement contribute to the susceptibility of diabetics to infections.
Krakauer T
Med Hypotheses; 2015 Dec; 85(6):997-1001. PubMed ID: 26384528
[TBL] [Abstract][Full Text] [Related]
19. microRNA-520c-3p suppresses NLRP3 inflammasome activation and inflammatory cascade in preeclampsia by downregulating NLRP3.
Liu Z; Zhao X; Shan H; Gao H; Wang P
Inflamm Res; 2019 Aug; 68(8):643-654. PubMed ID: 31143973
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients.
Zheng Q; Ren Y; Reinach PS; Xiao B; Lu H; Zhu Y; Qu J; Chen W
Exp Eye Res; 2015 May; 134():133-40. PubMed ID: 25701684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
